Drug distributor Cencora has entered into a definitive agreement to acquire Retina Consultants of America, a management services organization (MSO) of retina specialists, from Webster Equity Partners for $4.6 billion.
The University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery and Innovation, a research center that will focus on immunology and cell engineering with the goal of creating new cancer treatments and autoimmune disease treatments.
Technology company Astrana Health is acquiring certain assets of Prospect Health for $745 million.
The ability to use AI to get past cyber defenses will cause a reset on the tools used to secure healthcare networks, says cybersecurity expert Richard Staynings of the University of Denver.
Only a quarter of IT leaders and executives are confident about their cyber defense strategies, while a majority are at least somewhat confident, says Jill Brewer, market insights lead at HIMSS.
The HIMSS Chapter Advocacy Task Force allows for a unified voice for advocacy and mentorship, says Marjorie Rosen, HIMSS Chapter Advocacy vice chair.
More than 90% of messages can be handled by virtual nurses, which eases workforce shortages and burnout, says Anurag Mehta, CEO of Omega Healthcare.
Cigna confirmed today it is not pursuing a combination with Humana. The comments released in a statement affirming its capital priorities dismiss reports circulating earlier this fall that Cigna and Humana were in informal talks about a potential merger.
Independent pharmacy benefit manager CerpassRx is looking to better manage specialty drug spend by teaming up with Waltz Health on an artificial intelligence-powered platform called Intelligent Specialty Engine.
oVRcome can treat the 80% of people who have an anxiety disorder who cannot access a physical location, through Virtual Reality Exposure Therapy on a smartphone, says founder and CEO Adam Hutchinson.